HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ning Gu Selected Research

ferric ferrocyanide (Prussian blue)

9/2021Prussian Blue Nanozymes Prevent Anthracycline-Induced Liver Injury by Attenuating Oxidative Stress and Regulating Inflammation.
1/2021Zwitterion-functionalized hollow mesoporous Prussian blue nanoparticles for targeted and synergetic chemo-photothermal treatment of acute myeloid leukemia.
3/2018Sparks fly between ascorbic acid and iron-based nanozymes: A study on Prussian blue nanoparticles.
2/2016MRI of High-Glucose Metabolism Tumors: a Study in Cells and Mice with 2-DG-Modified Superparamagnetic Iron Oxide Nanoparticles.
8/2013[Comparison of the targeting properties of 2-deoxy-D-glucose-conjugated nanoparticles to breast cancer MDA-MB-231 cells and breast fibroblasts cells].
1/2012Targeting Glut1-overexpressing MDA-MB-231 cells with 2-deoxy-D-g1ucose modified SPIOs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ning Gu Research Topics

Disease

108Neoplasms (Cancer)
01/2022 - 10/2005
16Insulin Resistance
10/2022 - 03/2007
15Inflammation (Inflammations)
03/2022 - 12/2015
11Hyperthermia
12/2019 - 08/2005
9Glioma (Gliomas)
07/2021 - 01/2011
8Myocardial Infarction
06/2022 - 06/2007
8Type 2 Diabetes Mellitus (MODY)
01/2021 - 12/2004
8Breast Neoplasms (Breast Cancer)
12/2018 - 06/2008
8Multiple Myeloma
01/2017 - 01/2013
7Body Weight (Weight, Body)
08/2022 - 10/2015
7Coronary Artery Disease (Coronary Atherosclerosis)
01/2021 - 01/2015
7Neoplasm Metastasis (Metastasis)
01/2021 - 01/2015
7Leukemia
11/2018 - 10/2013
6Ventricular Remodeling
01/2022 - 01/2017
6Stroke (Strokes)
01/2022 - 01/2018
6Necrosis
09/2021 - 03/2011
6Hypertension (High Blood Pressure)
01/2021 - 09/2004
5Obesity
08/2022 - 04/2005
5Thrombosis (Thrombus)
01/2022 - 01/2013
5Melanoma (Melanoma, Malignant)
12/2021 - 04/2010
5Ischemic Stroke
09/2021 - 11/2014
5Lymphoma (Lymphomas)
09/2020 - 11/2014
5Ovarian Neoplasms (Ovarian Cancer)
08/2018 - 05/2008
5Liver Neoplasms (Liver Cancer)
12/2017 - 08/2005
5Hepatocellular Carcinoma (Hepatoma)
12/2017 - 12/2008
4Heart Failure
10/2022 - 04/2011
4Cardiovascular Diseases (Cardiovascular Disease)
06/2022 - 11/2010
4Fibrosis (Cirrhosis)
06/2022 - 01/2019
4Carcinoma (Carcinomatosis)
07/2021 - 05/2008
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 12/2014
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2022 - 01/2021
3Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2022 - 04/2011
3Non-alcoholic Fatty Liver Disease
03/2022 - 06/2021
3Hemorrhage
01/2022 - 09/2018
3Brain Ischemia (Cerebral Ischemia)
04/2017 - 12/2010
2Hypertriglyceridemia
08/2022 - 03/2012

Drug/Important Bio-Agent (IBA)

25Pharmaceutical PreparationsIBA
11/2021 - 08/2006
19Glucose (Dextrose)FDA LinkGeneric
10/2022 - 04/2005
16Proteins (Proteins, Gene)FDA Link
01/2021 - 09/2004
11LipidsIBA
10/2022 - 04/2005
11CytokinesIBA
10/2022 - 01/2009
11Therapeutic UsesIBA
01/2022 - 08/2005
10Contrast MediaIBA
01/2020 - 01/2011
10GoldIBA
11/2018 - 11/2014
9SilverIBA
01/2017 - 10/2013
8HydrogelsIBA
12/2019 - 07/2014
7EnzymesIBA
12/2022 - 06/2011
7Reactive Oxygen Species (Oxygen Radicals)IBA
07/2022 - 10/2013
7guanxin VIBA
06/2022 - 08/2020
7ferric oxide (iron oxide)IBA
01/2020 - 06/2007
6Biomarkers (Surrogate Marker)IBA
12/2021 - 11/2018
6IronIBA
11/2021 - 12/2008
6ferric ferrocyanide (Prussian blue)FDA Link
09/2021 - 01/2012
6Monoclonal AntibodiesIBA
08/2019 - 10/2013
6Cancer VaccinesIBA
08/2019 - 06/2007
6Succimer (Dimercaptosuccinic Acid)FDA Link
06/2017 - 01/2012
6Paclitaxel (Taxol)FDA LinkGeneric
01/2017 - 04/2012
6VaccinesIBA
09/2011 - 06/2007
5Liposomes (Liposome)IBA
07/2021 - 06/2008
5LigandsIBA
07/2021 - 09/2011
5Radiation-Sensitizing AgentsIBA
09/2017 - 12/2013
4Fatty Acids (Saturated Fatty Acids)IBA
03/2022 - 11/2015
4Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2021 - 01/2013
4AntioxidantsIBA
01/2021 - 11/2016
4ferriteIBA
08/2019 - 12/2006
4Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2019 - 01/2017
4Interleukin-6 (Interleukin 6)IBA
01/2019 - 01/2013
4DNA (Deoxyribonucleic Acid)IBA
11/2018 - 12/2007
4ErbB Receptors (EGF Receptor)IBA
06/2017 - 06/2011
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 03/2011
4Deoxyglucose (2 Deoxy D glucose)IBA
02/2016 - 04/2012
4Messenger RNA (mRNA)IBA
01/2014 - 10/2009
3CarbonIBA
07/2022 - 11/2021
3RivaroxabanIBA
01/2022 - 11/2019
3AntibodiesIBA
01/2022 - 04/2016
3Indicators and Reagents (Reagents)IBA
09/2021 - 02/2016
3AnticoagulantsIBA
04/2021 - 11/2019
3poly(lactide) (polylactic acid)IBA
01/2020 - 01/2014
3Rituximab (Mabthera)FDA Link
01/2020 - 11/2014
3Peroxidase (Myeloperoxidase)IBA
12/2019 - 06/2017
3Blood Glucose (Blood Sugar)IBA
11/2019 - 02/2010
3HomoharringtonineIBA
01/2017 - 01/2016
3interleukin-21 (interleukin 21)IBA
01/2011 - 01/2009
2RNA (Ribonucleic Acid)IBA
10/2022 - 10/2019
2Phosphates (Orthophosphate)IBA
08/2022 - 09/2011

Therapy/Procedure

51Therapeutics
01/2022 - 12/2007
13Radiotherapy
04/2018 - 12/2013
12Precision Medicine
09/2021 - 12/2013
8Microbubbles
01/2017 - 11/2008
7Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2021 - 11/2010
7Oral Administration
04/2020 - 08/2009
5Immunotherapy
09/2020 - 09/2008
5Drug Therapy (Chemotherapy)
01/2020 - 03/2011
4Injections
12/2019 - 10/2016
4Intravenous Administration
01/2019 - 04/2015
4Induced Hyperthermia (Thermotherapy)
01/2019 - 08/2006
3Percutaneous Coronary Intervention
01/2022 - 01/2021
3Stents
01/2022 - 01/2021
3Intravenous Injections
01/2019 - 11/2014
2Lasers (Laser)
01/2022 - 01/2018